NERV · NASDAQ
Minerva Neurosciences (NERV) Stock Price & Fundamentals
Minerva Neurosciences (NERV) closed at $500.12 on Oct 9, 2026, up 1.39% from the previous close of $493.28.
Share price, past year
1Y −0.41%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $500.12 |
| Sep 30, 2026 | $494.97 |
| Aug 31, 2026 | $520.20 |
| Jul 31, 2026 | $517.42 |
| Jun 30, 2026 | $516.53 |
| May 29, 2026 | $487.56 |
| Apr 30, 2026 | $459.34 |
| Mar 31, 2026 | $485.61 |
| Feb 27, 2026 | $468.63 |
| Jan 30, 2026 | $494.76 |
| Dec 31, 2025 | $496.67 |
| Nov 28, 2025 | $517.37 |
| Oct 31, 2025 | $488.16 |
Key statistics
- Market cap
- $23.62B
- P/E (TTM)
- —
- EPS (TTM)
- −$36.74
- Revenue (TTM)
- —
- Net income (TTM)
- −$394.35M
- Shares outstanding
- 47.2M
- Dividend yield
- —
- 52-week range
- $458.30 – $524.81
Minerva Neurosciences's market cap is $23.62B, based on a share price of $500.12 and 47.2M shares outstanding as of Jun 30, 2026.
Financials
Minerva Neurosciences reported revenue of $0.00 for fiscal 2024.
Minerva Neurosciences reported a net loss of $293.42M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $0.00 | — | $1.44M | — | $0.19 | — |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$30.01M | — | −$4.61 | — |
| FY2022ended Dec 31, 2022 | $0.00 | — | −$32.11M | — | −$6.01 | −$24.66M |
| FY2021ended Dec 31, 2021 | $0.00 | −100.0% | −$49.91M | — | −$9.35 | — |
| FY2020ended Dec 31, 2020 | $41.18M | — | $1.94M | 4.7% | $0.05 | — |
| FY2019ended Dec 31, 2019 | $0.00 | — | −$72.18M | — | −$1.85 | — |
| FY2018ended Dec 31, 2018 | $0.00 | — | −$50.17M | — | −$1.29 | — |
| FY2017ended Dec 31, 2017 | $0.00 | — | −$31.52M | — | −$0.83 | $3.04M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2021ended Mar 31, 2021 | $0.00 | — | — |
| Q2 FY2020ended Jun 30, 2020 | $41.18M | — | — |
| Q1 FY2020ended Mar 31, 2020 | $0.00 | — | — |
| Q1 FY2019ended Mar 31, 2019 | $0.00 | — | — |
| Q1 FY2018ended Mar 31, 2018 | $0.00 | — | — |
Company profile
- Name
- Minerva Neurosciences, Inc.
- Ticker
- NERV
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1500 District Avenue, Burlington, MA 01803
- Incorporated in
- MA
- Fiscal year ends
- December
- SEC CIK
- 0001598646
Recent SEC filings
- Aug 12, 2026
- Aug 7, 2026
- Aug 7, 2026
- Jun 4, 2026
- May 27, 2026
- May 5, 2026
- May 5, 2026
- Apr 6, 2026
Frequently asked questions
What is Minerva Neurosciences's stock price?
Minerva Neurosciences (NERV) closed at $500.12 on Oct 9, 2026, up 1.39% from the previous close of $493.28.
What is Minerva Neurosciences's market cap?
Minerva Neurosciences's market cap is $23.62B, based on a share price of $500.12 and 47.2M shares outstanding as of Jun 30, 2026.
How much revenue does Minerva Neurosciences make?
Minerva Neurosciences reported revenue of $0.00 for fiscal 2024.
Does Minerva Neurosciences pay a dividend?
Minerva Neurosciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Minerva Neurosciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures